Physician profile
Michael Kachmar
NPI 1366422271
$366.94
in general payments reported to CMS, 2019-2025
9 companies · $21.17 in 2025
The $21.17 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.47 · 2021: $93.95 · 2022: $30.11 · 2023: $82.18 · 2024: $119 · 2025: $21.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $93.95 | 2021 | |
| Heron Therapeutics, INC. | $61.14 | 2023 | Aponvie |
| Solventum Corporation | $53.84 | 2024-2025 | Activ.A.C. |
| Organogenesis INC. | $53.25 | 2024 | Affinity |
| Paratek Pharmaceuticals, INC. | $33.14 | 2024 | Nuzyra |
| Integra Lifesciences Corporation | $21.04 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Zimmer Biomet Holdings, INC. | $20.47 | 2020 | |
| Bard Peripheral Vascular, INC. | $15.73 | 2022 | |
| Bioventus LLC | $14.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kachmar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.